News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Bukofzer Stan
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/03/2020 |
4
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc
Txns:
| Paid exercise price by delivering 7,433 shares
@ $0 Exercised 25,370 restricted stock units
@ $0 |
|
02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/06/2020 |
4
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc
Txns:
| Granted 326,577 restricted stock units
@ $0 |
|
08/14/2019 |
4
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc
Txns:
| Bought 4,000 shares
@ $1.557, valued at
$6.2k
|
|
04/03/2019 |
4
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc
Txns:
| Paid exercise price by delivering 7,434 shares
@ $5.16, valued at
$38.4k
Exercised 25,370 restricted stock units
@ $0 |
|
03/18/2019 |
4
| Bukofzer Stan (SVP, Chf Scitfc & Tech Officer) has filed a Form 4 on Assertio Therapeutics, Inc
Txns:
| Bought 5,000 shares
@ $4.1315, valued at
$20.7k
|
|
02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/04/2018 |
4
| Bukofzer Stan (Chief Medical Officer & SVP***) has filed a Form 4 on DEPOMED INC
Txns:
| Granted 91,324 restricted stock units
@ $0 |
|
12/11/2017 |
4
| Bukofzer Stan (Chief Medical Officer) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns:
| Disposed/sold 2,500 shares
@ $1.52, valued at
$3.8k
Disposed/sold 200,000 shares
@ $1.52, valued at
$304k
Disposed/sold 300,000 options to buy
@ $3.06, valued at
$918k
Disposed/sold 208,350 options to buy
@ $2.15, valued at
$448k
|
|
03/30/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|